Stay updated on Ubrogepant Clinical Trial
Sign up to get notified when there's something new on the Ubrogepant Clinical Trial page.

Latest updates to the Ubrogepant Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedAdded a consolidated Locations section listing study sites by state (Revision: v3.3.3) and removed the separate per-state location entries.SummaryDifference2%

- Check28 days agoNo Change Detected
- Check49 days agoChange DetectedEditorial notes were updated to clarify that publications are automatically filled from PubMed and to display the current revision (v3.3.2). The old description of PubMed-listed publications and the previous revision (v3.2.0) were removed.SummaryDifference0.1%

- Check57 days agoChange DetectedThe government funding/operating status notice has been removed from the page, eliminating the banner text that referenced cc.nih.gov and opm.gov.SummaryDifference0.2%

- Check71 days agoChange DetectedThe screenshots show updates to the study locations/sites list, with multiple sites added and/or removed across various states. These changes alter where potential participants can enroll and whom to contact for participation.SummaryDifference0.2%

- Check100 days agoChange DetectedUpdated version to v3.2.0 and added a government funding lapse notice affecting site reliability; removed the older v3.1.0 reference.SummaryDifference2%

- Check107 days agoChange DetectedIncremental version update: replacing the old revision tag v3.0.2 with a new v3.1.0.SummaryDifference0.1%

Stay in the know with updates to Ubrogepant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ubrogepant Clinical Trial page.